EMA’s envisaged risk-based and human-centric approach to regulate AI

Bird & Bird’s international life sciences and healthcare team is at the forefront of the legal developments with regard to AI and the life sciences sector. This article is part of our new series, which will highlight different legal angles to consider when implementing AI in the life sciences and healthcare industry.

Latest insights

More Insights
Car on a road between forest and water

Navigating the shift to electric vehicles and sustainable practices in the automotive industry

Dec 06 2023

Read More
multicoloured curiosity line on blue background

ICO Enforcement Updates (PECR) - December 2023

Dec 06 2023

Read More
Cyclists and pedestrians on curved road

The continuing rise of Consumer Litigation in the EU: a deep dive into current trends - Trend 1 - Consumer Class Actions

Dec 06 2023

Read More